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PM and Elevated
Inflammation Markers 
More Support for Air Pollution–Heart Disease Link
After evaluating about 1,000 Europeans already suffering from cardio-
vascular disease, researchers have found a relationship between elevat-
ed concentrations of airborne particulates (PM) and increases in two
markers of inflammation that have strong links with cardiovascular
diseases and deaths [EHP 115:1072–1080; Rückerl et al.]. The
cumulative number of people studied is the largest to date for PM and
these inflammation indicators, with the findings generally consistent
across diverse locales. 
The researchers evaluated about 100 to 200 myocardial infarction
survivors in each of six cities around the continent: Athens, Augsburg,
Barcelona, Helsinki, Rome, and Stockholm. The cities have a wide
range of demographic profiles, climates, and air pollutant concentra-
tions. The selected people tended to be male, elderly, overweight, and
consumers of numerous prescription drugs.
To evaluate inflammation, the researchers studied interleukin 6
(IL-6; thought to play a central role in triggering inflammation)
and two proteins, fibrinogen and C-reactive protein (CRP), whose
synthesis is stimulated by IL-6. They also considered the potentially
confounding effects of many other variables, such as smoking sta-
tus, presence of diabetes, time of day, and season.
They found that IL-6 increased most when particle number con-
centration—an indicator of ultrafine particulates—was elevated 12
to 17 hours before a blood draw. They also found that increased fib-
rinogen was associated with cumulative five-day exposure to larger
particulates (PM10). In addition, the results indicated associations
between fine particulates (PM2.5) and fibrinogen, and between
nitrogen dioxide and IL-6. 
There were a few anomalies that remain to be explained, such as
the fact that the strongest link between PM10 exposures and increased
fibrinogen after three days occurred in Helsinki, even though that city
had the lowest PM10 concentrations of the six studied. There were no
consistent patterns for CRP, although the results may have been
skewed by the fact that most of the people studied consumed statins,
cholesterol-lowering drugs known to reduce this protein.
Much remains unknown about the links between the inflamma-
tion indicators tracked and subsequent health effects. Nonetheless,
this study may help explain conflicting results of similar work, since
it better addresses previous limitations such as lack of geographic
diversity, small subject population, limited number of inflammation
indicators tested, and variable health status. –Bob Weinhold
Resisting Arrest
Drug-Resistant Campylobacter Persists in Poultry
Doctors use the fluoroquinolone class of antibiotics to treat food
poisoning caused by Campylobacter. But after poultry farmers
began using fluoroquinolones to treat respirato-
ry disease in flocks, the drugs became less
effective in people. In 2005,
the FDA banned the use
of fluoroquinolones
on poultry farms because of these concerns. A new study now
suggests that the ban may not be enough to fix the problem
[EHP 115:1035–1039; Price et al.]. 
A team of Johns Hopkins researchers made weekly trips to
Baltimore supermarkets for 20 weeks in 2004 and 15 weeks in
2006. Each week, they bought chicken from each of five different
producers. Three producers had never used any antibiotics; two
were major conventional producers that declared they had ceased
all use of fluoroquinolones in 2002, three years before the FDA
ban. The scientists tested one piece of chicken from each package
for Campylobacter, confirmed the bacterium’s identity using DNA
analysis, then tested for antibiotic resistance using the minimal
inhibitory concentration method. 
The bacteria from conventional chicken were more likely to
be fluoroquinolone-resistant than those from antibiotic-free prod-
ucts. The researchers compared each poultry producer to every
other producer in a pair-wise fashion. In both 2004 and 2006,
this statistical analysis showed that the Campylobacter strains from
the conventionally produced chicken were more likely to be resis-
tant than the strains from antibiotic-free samples.
In addition, between 2004 and 2006, the proportion of
antibiotic-resistant bacteria on the conventionally produced
chicken showed no significant change, indicating that the preva-
lence of fluoroquinolone-resistant Campylobacter was not decreas-
ing in chicken from these producers, even after four years. 
The results suggest that once antibiotic-resistant bacteria have
developed, they may show up on grocery store shelves long after
drug use stops. The authors note that they could not verify claims
of voluntary fluoroquinolone prohibition because poultry produc-
ers are not required to report their use of drugs in food animals to
regulatory agencies. 
Other studies have shown that resistant bacteria can linger in
poultry farms’ water distribution and ventilation systems and in
reused litter. The authors state that additional interventions, such
as requiring thorough disinfection and regular litter changing in
poultry houses, may be necessary to reduce the public health bur-
den of fluoroquinolone-resistant Campylobacter. –Angela Spivey
A 362 VOLUME 115 | NUMBER 7 | July 2007 • Environmental Health PerspectivesScience Selections
Environmental Health Perspectives • VOLUME 115 | NUMBER 7 | July 2007 A 363
D
i
e
t
e
r
 
T
e
l
e
m
a
n
s
/
P
a
n
o
s
 
P
i
c
t
u
r
e
s
Manganese and Infant Mortality
Well Water May Raise Death Rates in Bangladesh
Many wells in Bangladesh exceed the WHO threshold for man-
ganese of 0.4 mg/L—in the Araihazar region in eastern Bangladesh,
80% of the wells provide water with manganese concentrations
above 0.5 mg/L. A new study now suggests that manganese exposure
through drinking water may contribute to Bangladesh’s extremely
high infant mortality rate of 54 per 1,000 live births [EHP
115:1107–1112; Hafeman et al.].
Well water in Bangladesh already receives close scrutiny for its
naturally high levels of arsenic, a known carcinogen. Manganese is
also a concern, however, due to research showing associations
between exposure and subclinical neurological effects in adults and
decreased intellectual function in children. Additionally, neonatal
animal studies have linked reduced weight gain and decreased sur-
vival to manganese exposure.
An ongoing cohort study in Araihazar, the Health Effects of
Arsenic Longitudinal Study (HEALS), provided the framework for
investigating whether manganese might affect human infant survival.
Of the HEALS participants, 1,628 women met the criteria for the
current study: they married before age 40, drank from the same well
for most of their reproductive years, and reported at least one live
birth. The researchers considered concentrations of manganese and
other metals in the wells used by the target population, the mothers’
reproductive history and education, and the families’ socioeconomic
status and other factors that can affect infant survival.
Although breastfeeding rates are high in Bangladesh, newborns are
often given sugar water in place of colostrum, and most young infants
receive complementary foods by age 6 months. Of the 3,824 infants
born to the study group, nearly 85% were exposed to water man-
ganese levels above 0.4 mg/L, and 335 died before age 1 year, an ele-
vated risk of death not explained by measured covariates. The finding
was more pronounced when restricted to women married after 1991,
who appeared to give more complete reproductive histories; among
these women, the infant death rate was 82 per 1,000 live births.
No dose–response relationship was seen, though, and the associ-
ation was not found when analysis was restricted to water samples
collected for the current study. The researchers recommend design-
ing a study specifically to investigate the role of manganese exposure
in infant mortality, with particular attention to causes of mortality
and potential routes of exposure. –Julia R. Barrett
New Phthalate Link?
DEHP Metabolites and Altered Thyroid Hormone
Levels in Men
Human studies have shown widespread exposure to phthalates,
compounds used in the manufacture of household, consumer, and
medical products. The plasticizer DEHP is one of the most widely
used chemicals in this class. A limited number of rat studies have
linked DEHP exposure to alterations in thyroid signaling and lower
plasma thyroxine (T4) concentrations. Now a study of adult men
for the first time shows an association between higher urinary levels
of the metabolite MEHP and reduced thyroid hormone in blood
serum [EHP 115:1029–1034; Meeker et al.]. 
Phthalates are metabolized and excreted quickly; these metabo-
lites, rather than the parent diesters, are believed to be the active
toxicants. Ingested DEHP is initially hydrolyzed in the intestine to
MEHP. The metabolites MEOHP and MEHHP are then pro-
duced by the oxidation of MEHP. 
The study participants included 408 men between the ages of
18 and 55. All were partners in subfertile couples who visited a
Boston fertility center between January 2000 and May 2004. Each
man completed a questionnaire and provided urine and blood samples
on the same day. Blood samples were analyzed for free T4, total tri-
iodothyronine (T3), and thyroid-stimulating hormone. Urine
analysis provided data on concentrations of DEHP metabolites. 
MEHP was detected in 83% of the 408 samples. MEOHP and
MEHHP were found in more than 95% of 208 samples tested (the
sample size was smaller because methods for analyzing these
metabolites became available only later in the study).
Multivariate regression analysis revealed a statistically significant
inverse association between urine MEHP concentrations and serum
total T3 levels. In an effort to determine whether individual differ-
ences in the ability to further metabolize and neutralize MEHP
might explain this relationship, the researchers also calculated the
percentage of MEHP relative to the other metabolites. They found
a weaker though still statistically significant inverse association
between the percentage of MEHP relative to the other metabolites
and free T4 levels.
This suggests that an individual’s ability to metabolize and neu-
tralize MEHP may play a role in determining effects. The
researchers urge other scientists to consider whether MEHP levels
relative to other metabolite concentrations might serve as potential
markers for metabolic vulnerability to adverse effects from DEHP
exposure. –Rebecca Renner
Mother and newborn in Dhaka, Bangladesh